The event will be held from September 4–6, 2025, at Bharat Mandapam, New Delhi
iPHEX 2025, the 11th Edition of the International Exhibition and Healthcare is scheduled from September 4–6, 2025, at Bharat Mandapam, New Delhi. Organised by the Pharmexcil (Pharmaceuticals Export Promotion Council of India), with the support of the Ministry of Commerce and Industry, the event will convene key stakeholders from the pharmaceutical industry and allied sectors.
The event will feature a dedicated international buyers and sellers meet, a focussed exhibition with over 700 stalls with a strong emphasis on research and development and innovation. It will also spotlight India’s leading pharmaceutical exporters across formulations, biosimilars, bulk drugs, and surgical products, who are serving healthcare needs in over 150 countries. These capabilities will be showcased through the flagship International Exhibition on Pharmaceuticals and Healthcare (iPHEX).
Namit Joshi, Chairman of Pharmexcil, commented, “Now in its 11th edition, iPHEX has firmly established itself as a flagship global platform that showcases India’s pharmaceutical excellence. This year, the event expands its scope to include allied segments such as pharmaceutical machinery and Ayush products, broadening its relevance and impact. iPHEX has consistently created synergy and confidence among global pharma stakeholders, offering an exclusive environment for focussed one-on-one business meetings, regulatory dialogues, and strategic partnerships. Our objective is to reinforce India’s position as the preferred global partner for high-quality, affordable pharmaceuticals.”
Vice Chairman of Pharmexcil, Bhavin Mehta also shared his perspective on the event, “iPHEX 2025 is a cornerstone in India’s pharmaceutical trade diplomacy, uniquely designed to go beyond a traditional exhibition. With participation from regulators and buyers across NAFTA, EU, Africa, ASEAN, CIS, LAC, and WANA regions, the event facilitates deep engagement through contract manufacturing discussions, technology transfers, and bilateral trade collaborations. As a niche, high-value platform, iPHEX continues to drive market access and position India as an innovation-led, reliable force in global pharma supply chains.”
